ORGNHIGH SIGNALFINANCIAL10-K

ORGN executed a 1:30 reverse stock split in March 2026 amid substantial deterioration in financial performance, with revenue declining meaningfully and balance sheet assets contracting significantly.

The reverse stock split typically signals serious financial distress and potential delisting concerns, suggesting the company's stock price had fallen below exchange minimum requirements. The combination of declining revenue, substantial asset contraction, and increased liabilities indicates ORGN is experiencing operational challenges that may threaten its business continuity.

Comparing 2026-03-30 vs 2025-03-13View on EDGAR →
FINANCIAL ANALYSIS

ORGN's financial position deteriorated substantially, with total assets contracting by 58% to $157.7M and stockholders' equity declining by 69% to $104.2M. Revenue dropped meaningfully from $31.3M to $18.9M, while total liabilities increased 35% to $53.4M, creating a concerning financial profile. The company did show modest improvement in operating cash flow losses, though they remain substantial at -$32.8M, and cash reserves declined significantly to $32.9M, raising liquidity concerns.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
-69.2%
$338.4M$104.2M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Total Assets
Balance Sheet
-58.3%
$378.0M$157.7M

Total assets contracted 58.3% — asset sales, write-downs, or balance sheet optimization underway.

Current Assets
Balance Sheet
-41.9%
$139.2M$80.9M

Current assets declined 41.9% — monitor working capital adequacy and short-term liquidity.

Cash & Equivalents
Balance Sheet
-41.5%
$56.3M$32.9M

Cash declined 41.5% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Revenue
P&L
-39.5%
$31.3M$18.9M

Revenue declined 39.5% — significant demand weakness or market share loss warrants investigation.

Operating Cash Flow
Cash Flow
+35.5%
-$50.8M-$32.8M

Operating cash flow surged 35.5% — exceptional cash generation, highest quality earnings signal.

Total Liabilities
Balance Sheet
+34.8%
$39.7M$53.4M

Liabilities grew 34.8% — significant increase in debt or obligations, assess impact on financial flexibility.

Accounts Receivable
Balance Sheet
-32%
$19.2M$13.0M

Receivables declined — improved collection efficiency or conservative revenue recognition.

R&D Expense
P&L
-25.9%
$18.6M$13.7M

R&D spending cut 25.9% — could signal cost discipline or concerning reduction in innovation investment.

Inventory
Balance Sheet
-21%
$866K$684K

Inventory reduced 21% — lean inventory management or demand outpacing supply.

LANGUAGE CHANGES
NEW — 2026-03-30
PRIOR — 2025-03-13
ADDED
The registrant had issued and outstanding an aggregate of 5,425,037 shares of common stock as of March 20, 2026.
If such Proxy Statement is not filed within 120 days after the end of the registrant s fiscal year covered by this Annual Report on Form 10 K, such information will be included in an amendment to this Annual Report on Form 10 K to be filed within such 120-day period.
Market for Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 46 Item 6.
Management s Discussion and Analysis of Financial Condition and Results of Operations 47 Item 7A.
1 EXPLANATORY NOTE REVERSE STOCK SPLIT On March 19, 2026, we filed with the Secretary of State of the State of Delaware a Certificate of Amendment to our Certificate of Incorporation (the Amendment ), to effect a one-for-thirty (1:30) reverse stock split of our issued and outstanding common stock, effective as of March 19, 2026 (the Reverse Stock Split ).
+7 more — sign up free →
REMOVED
The registrant had issued and outstanding an aggregate of 149,354,886 shares of common stock as of March 7, 2025.
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 39 Item 6.
Management's Discussion and Analysis of Financial Condition and Results of Operations 41 Item 7A.
For more detailed descriptions of each risk factor, see item 1A titled Risk Factors.
Our business plan assumes we can secure substantial additional project financing and/or government incentives, which may be unavailable on favorable terms, if at all.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →